paroxetine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases hamilton Depression Rating Scale (HDRS) total score
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“The HAMD score showed significant decrease in the paroxetine treatment group compared to control group (SMD -2.14, 95% CI -2.73 to -1.56, P <.00001).”
Quoted verbatim from The effects of paroxetine therapy on depressive symptom and motor function in the treatment of depression with Parkinson's disease: A meta-analysis.. - Study
- meta-analysis
- Dose
- 20 mg/d in most trials
- Population
- Patients with depression and idiopathic Parkinson's disease; paroxetine added to background anti-parkinsonian drug therapy versus that therapy alone (or placebo in 3 trials); 25 trials, 2126 patients
Effect -2.14 standardised mean difference, 95% CI -2.73 to -1.56
The effects of paroxetine therapy on depressive symptom and motor function in the treatment of depression with Parkinson's disease: A meta-analysis.2023PMID:37653795Permalink
Keep reading
- Everything the graph holds on paroxetine
- Every compound studied against Hamilton Depression Rating Scale (HDRS) total score
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45E79DA9EGCVH0JD19N5DEY